seen from Argentina
seen from United States
seen from China
seen from United States
seen from Malaysia
seen from United States
seen from United States
seen from China
seen from Azerbaijan
seen from China
seen from Malta
seen from United States
seen from Australia
seen from Azerbaijan
seen from Germany
seen from T1
seen from Malaysia
seen from Croatia
seen from T1
seen from T1
Failure of Vytorin and Statins to Improve Cardiovascular Health
The clinical failure of Vytorin in the ENHANCE trial supports the need to reevaluate the efficacy of widespread use of statin drugs for the treatment and prevention of coronary artery disease (CAD).
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
more pharma pens
Study lifts cloud over heart drugs Zetia, Vytorin
CHICAGO – A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found these pills modestly lower the risk of heart attacks and other problems in people at high risk for them – evidence that’s been missing for more than a decade as the drugs racked up billions in sales. Study lifts cloud over heart drugs Zetia, Vytorin
Study lifts cloud over heart drugs Zetia, Vytorin
CHICAGO - A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly... Study lifts cloud over heart drugs Zetia, Vytorin
Study lifts cloud over heart drugs Zetia, Vytorin
CHICAGO (AP) — Drugmaker Merck & Co. says its cholesterol-lowering medicine ezetimibe (uh-ZETT-uh-mibe) met its main goal in a study testing whether adding it to an older type of cholester… Study lifts cloud over heart drugs Zetia, Vytorin
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Remember those wonderful Vytorin commercials where everybody looked like their food?
降膽固醇藥Vytorin 可致嚴重心臟病......
降膽固醇藥Vytorin 可致嚴重心臟病 (明報) 01月 16日 星期三 05:05AM
【明報專訊】美國 一種名為Vytorin的降膽固醇藥，在一個臨牀實驗中，被發現可能導致病人血液凝結成血塊造成血管阻塞，引發嚴重心臟疾病，另一種藥物「Zetia」則證實無法有效防止心臟病 和中風 。
香港藥劑師學會教育總監崔俊明對研究表示震驚，呼籲曾服用病人到負責處方醫生檢查，本地衛生署 指，Zetia和Vytorin均在港註冊，會留意有關報告。
Zetia未能降心臟病中風發病率
外電引述，出產有關降膽固醇藥的默克和先靈葆雅公司（Schering Plough）花兩年時間進行藥物研究，安排720名高膽固醇病人，分別服食Zetia和Vytorin。結果顯示，大多數病人服用Zetia後，膽固醇水平降低15%至20%，但所有臨牀數據顯示該藥不可降低心臟病和中風的發病率。
服食Vytorin的病人更會加速血液凝結血塊問題，不但無效，更可能引致各種嚴心疾病。
藥劑師學會籲服用病人做檢查
崔俊明表示，Vytorin是新興藥物，多數由私家醫生處方，本地公立醫院常用另一藥物「Lipitor」。他對研究表示震驚，憂慮Vytorin引致病人出現中風及心臟病，呼籲曾服用病人到負責處方的醫生進行檢查。
